Cargando…

Heterogeneity of glycan biomarker clusters as an indicator of recurrence in pancreatic cancer

Mostrar otras versiones (1)

INTRODUCTION: Outcomes following tumor resection vary dramatically among patients with pancreatic ductal adenocarcinoma (PDAC). A challenge in defining predictive biomarkers is to discern within the complex tumor tissue the specific subpopulations and relationships that drive recurrence. Multiplexed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wisniewski, Luke, Braak, Samuel, Klamer, Zachary, Gao, ChongFeng, Shi, Chanjuan, Allen, Peter, Haab, Brian B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10130372/ https://www.ncbi.nlm.nih.gov/pubmed/37124496 http://dx.doi.org/10.3389/fonc.2023.1135405

Ejemplares similares

Heterogeneity of Glycan Biomarker Clusters as an Indicator of Recurrence in Pancreatic Cancer
por: Wisniewski, Luke, et al.
Publicado: (2023)

Advances in Tools to Determine the Glycan-Binding Specificities of Lectins and Antibodies
por: Haab, Brian B., et al.
Publicado: (2020)

Imaging Mass Spectrometry and Lectin Analysis of N-Linked Glycans in Carbohydrate Antigen–Defined Pancreatic Cancer Tissues
por: McDowell, Colin T., et al.
Publicado: (2020)

Deciphering Protein Glycosylation by Computational Integration of On-chip Profiling, Glycan-array Data, and Mass Spectrometry
por: Klamer, Zachary, et al.
Publicado: (2019)

CarboGrove: a resource of glycan-binding specificities through analyzed glycan-array datasets from all platforms
por: Klamer, Zachary L, et al.
Publicado: (2022)

Bioorthogonal Chemical Labeling Probes Targeting Sialic Acid Isomers for N-Glycan MALDI Imaging Mass Spectrometry of Tissues, Cells, and Biofluids
por: Lu, Xiaowei, et al.
Publicado: (2023)

Mining High-Complexity Motifs in Glycans: A New Language To Uncover the Fine Specificities of Lectins and Glycosidases
por: Klamer, Zachary, et al.
Publicado: (2017)

The Roles of Glycans in Bladder Cancer
por: Jian, Yuli, et al.
Publicado: (2020)

Editorial: Triple-negative breast cancer: Heterogeneity, tumor microenvironment and targeted therapy
por: Deng, Xiyun, et al.
Publicado: (2022)

Multiple Roles of Glycans in Hematological Malignancies
por: Pang, Xingchen, et al.
Publicado: (2018)

Pancreatic Cancer Heterogeneity Can Be Explained Beyond the Genome
por: Juiz, Natalia Anahi, et al.
Publicado: (2019)

Quantitative Characterization of CD8+ T Cell Clustering and Spatial Heterogeneity in Solid Tumors
por: Gong, Chang, et al.
Publicado: (2019)

Role of Glycans in Cancer Cells Undergoing Epithelial–Mesenchymal Transition
por: Li, Xiang, et al.
Publicado: (2016)

Circulating Glycan Monosaccharide Composite-Based Biomarker Diagnoses Colorectal Cancer at Early Stages and Predicts Prognosis
por: Li, Haoran, et al.
Publicado: (2022)

The Sweet Side of Immune Evasion: Role of Glycans in the Mechanisms of Cancer Progression
por: Nardy, Ana Flávia Fernandes Ribas, et al.
Publicado: (2016)

Use of Mass Spectrometry to Screen Glycan Early Markers in Hepatocellular Carcinoma
por: de Oliveira, Raphaela Menezes, et al.
Publicado: (2018)

Current Challenges in Glioblastoma: Intratumour Heterogeneity, Residual Disease, and Models to Predict Disease Recurrence
por: Ellis, Hayley P., et al.
Publicado: (2015)

Glycans Related to the CA19-9 Antigen Are Increased in Distinct Subsets of Pancreatic Cancers and Improve Diagnostic Accuracy Over CA19-9
por: Tang, Huiyuan, et al.
Publicado: (2015)

Circulating tumor cell associated white blood cell cluster as a biomarker for metastasis and recurrence in hepatocellular carcinoma
por: Chen, Jing, et al.
Publicado: (2022)

Temporal genomic heterogeneity guiding individualized therapy in recurrent non-small cell lung cancer
por: Fang, Qiyu, et al.
Publicado: (2023)

MUC16 and TP53 family co-regulate tumor-stromal heterogeneity in pancreatic adenocarcinoma
por: Chirravuri-Venkata, Ramakanth, et al.
Publicado: (2023)

Molecular profiling and specific targeting of gemcitabine-resistant subclones in heterogeneous pancreatic cancer cell populations
por: Färber, Benedikt, et al.
Publicado: (2023)

Conformational Heterogeneity of the HIV Envelope Glycan Shield
por: Yang, Mingjun, et al.
Publicado: (2017)

Whole-Exome Sequencing Reveals Recurrent but Heterogeneous Mutational Profiles in Sporadic WHO Grade 1 Meningiomas
por: González-Tablas, María, et al.
Publicado: (2021)

Prognostic and recurrent significance of SII in patients with pancreatic head cancer undergoing pancreaticoduodenectomy
por: Chen, Qing, et al.
Publicado: (2023)

The Microbiome Tumor Axis: How the Microbiome Could Contribute to Clonal Heterogeneity and Disease Outcome in Pancreatic Cancer
por: Basu, Meghna, et al.
Publicado: (2021)

Identification and characterization of interferon-γ signaling-based personalized heterogeneity and therapeutic strategies in patients with pancreatic cancer
por: Chen, Xu, et al.
Publicado: (2023)

Performance comparison of 2D and 3D MRI radiomics features in meningioma grade prediction: A preliminary study
por: Duan, Chongfeng, et al.
Publicado: (2023)

Machine-learning based investigation of prognostic indicators for oncological outcome of pancreatic ductal adenocarcinoma
por: Chang, Jeremy, et al.
Publicado: (2022)

Turning-Off Signaling by Siglecs, Selectins, and Galectins: Chemical Inhibition of Glycan-Dependent Interactions in Cancer
por: Cagnoni, Alejandro J., et al.
Publicado: (2016)

Abnormal ECA-Binding Membrane Glycans and Galactosylated CAT and P4HB in Lesion Tissues as Potential Biomarkers for Hepatocellular Carcinoma Diagnosis
por: Kong, Ying, et al.
Publicado: (2022)

Reveal the Heterogeneity in the Tumor Microenvironment of Pancreatic Cancer and Analyze the Differences in Prognosis and Immunotherapy Responses of Distinct Immune Subtypes
por: Wang, Xiaoqin, et al.
Publicado: (2022)

Serum exosomal and serum glypican-1 are associated with early recurrence of pancreatic ductal adenocarcinoma
por: Zhao, Juan, et al.
Publicado: (2022)

Glycan heterogeneity as a cause of the persistent fraction in HIV-1 neutralization
por: Ringe, Rajesh P., et al.
Publicado: (2023)

Integrated Glycome Strategy for Characterization of Aberrant LacNAc Contained N-Glycans Associated With Gastric Carcinoma
por: Yu, Hanjie, et al.
Publicado: (2019)

Structural Heterogeneity of Terminal Glycans in Campylobacter jejuni Lipooligosaccharides
por: Semchenko, Evgeny A., et al.
Publicado: (2012)

Spatial transcriptomics reveals the heterogeneity and FGG+CRP+ inflammatory cancer-associated fibroblasts replace islets in pancreatic ductal adenocarcinoma
por: Ren, Zhangyong, et al.
Publicado: (2023)

Stereotactic Body Radiation Therapy for Locally Progressive and Recurrent Pancreatic Cancer after Prior Radiation
por: Sutera, Philip, et al.
Publicado: (2018)

Pancreatic metastasis from locally recurrent neuroendocrine differentiated prostate cancer after radical prostatectomy
por: Ando, Takashi, et al.
Publicado: (2020)

Perioperative Serum Scoring Systems Predict Early Recurrence and Poor Prognosis of Resectable Pancreatic Cancer
por: Li, Shengnan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ue95eiurae96rem108sqieurhq